Epilepsy


After researching the safety and effectiveness of CBD oil for treating epilepsy, the FDA approved the use of CBD (Epidiolex) as a therapy for two rare conditions characterized by epileptic seizures in 2018.

In the U.S., a doctor can prescribe Epidiolex to treat:

  • Lennox-Gastaut syndrome (LGS), a condition that appears between the ages of 3 and 5 years and involves different kinds of seizures
  • Dravet syndrome (DS), a rare genetic condition that appears in the first year of life and involves frequent, fever-related seizures

The types of seizures that characterize LGS or DS are difficult to control with other types of medication.

The FDA specified that doctors could not prescribe Epidiolex for children younger than 2 years. A physician or pharmacist will determine the right dosage based on body weight.



Advertisements